ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study
NCT ID: NCT06377150
Last Updated: 2025-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2022-04-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spine Deformities in Juvenile Idiopathic Arthritis
NCT04664231
A Natural History Study of Infantile Neuroaxonal Dystrophy
NCT04027816
Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
NCT02078401
Microbiologic Findings of Acute Facial Palsy in Children
NCT01537952
Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease
NCT02752191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Kuehlewein, MD
Role: PRINCIPAL_INVESTIGATOR
Centre for Ophthalmology, University of Tuebingen
Susanne Kohl, PhD
Role: PRINCIPAL_INVESTIGATOR
Molecular Genetics Laboratory, Centre for Ophthalmology, University of Tuebingen
Jan-Philipp Bodenbender, MD
Role: PRINCIPAL_INVESTIGATOR
Centre for Ophthalmology, University of Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tuebingen
Tübingen, Baden-Wuerttemberg, Germany, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABCA4-1382022BO2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.